Prescribing for the elderly. Part I: Sensitivity of the elderly to adverse drug reactions.
about
Antibiotic duration for treating uncomplicated, symptomatic lower urinary tract infections in elderly womenAntibiotic duration for treating uncomplicated, symptomatic lower urinary tract infections in elderly women.Healthcare costs and utilization for Medicare beneficiaries with Alzheimer'sIs the public being protected? Prevention of suboptimal medical practice through training programs and credentialing examinations.Challenges of prescribing low-dose drug therapy for older people.Appropriateness of medication selection for older persons in an urban academic emergency department.Economic and humanistic impact of adverse events associated with CSFs.Polypharmacy in the HIV-infected older adult population.Longitudinal trends in prescribing for elderly patients: two surveys four years apart.Polypharmacy and hospitalization among older home care patients.A systematic review of hospitalization resulting from medicine-related problems in adult patients.Pain management in older adults: prevention and treatment.Suboptimal prescribing in older inpatients and outpatients.Differences in medication use in the Alzheimer's disease neuroimaging initiative: analysis of baseline characteristicsQuestionable prescribing for elderly patients in Quebec.Efficacy and safety of angiotensin II receptor blockers in elderly patients with mild to moderate hypertension.A survey on polypharmacy and use of inappropriate medications.An evidence-based approach to prescribing NSAIDs in musculoskeletal disease: a Canadian consensus. Canadian NSAID Consensus Participants.Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender.Clinical implications of changes in hepatic drug metabolism in older peopleThe clinical pharmacology of ageing.Geriatric care approaches in health maintenance organizations.Drug related medical emergencies in the elderly: role of adverse drug reactions and non-complianceInfluence of age on the enantiomeric disposition of ibuprofen in healthy volunteersClinical pharmacy interventions by community pharmacists during the dispensing process.What drugs are our frail elderly patients taking? Do drugs they take or fail to take put them at increased risk of interactions and inappropriate medication use?Heart failure in the oldest patients: the impact of comorbid conditions.Chronic Condition Clusters and Polypharmacy among Adults.Effect of coexisting chronic obstructive pulmonary disease and cognitive impairment on health outcomes in older adultsAssessing multiple medication use with probabilities of benefits and harms.Underuse of medications for chronic diseases in the oldest of community-dwelling older frail Japanese.Comprehensive care for the elderly.Screening an elderly population for verifiable adverse drug reactions. Methodological approach and initial data of the Berlin Aging Study (BASE).Percutaneous transluminal coronary angioplasty in patients 70 years of age or older: 12 years' experienceSystematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care.Inappropriate drug use and risk of transition to nursing homes among community-dwelling older adults.Pharmacologic consideration for the use of antiretroviral agents in the elderly.Emergency department visits and admissions due to drug related problems at Riyadh military hospital (RMH), Saudi ArabiaGeropharmacology: an individualized approach.Medication reviews with computerised expert support: evaluation of a method to improve the quality of drug utilisation in the elderly.
P2860
Q24241941-ED7A91C1-AE98-41E1-80C5-D3CC012E6A7EQ30838748-BB529980-CAE7-4AA1-900C-E529CCEC701CQ33156304-047D1F27-4330-4673-BD02-DA5B695ECF07Q33554823-471485AF-0BBD-4302-ACB5-B80248918545Q33596150-EE766734-F3AF-4125-AB7D-0C7E968C31EFQ33803357-D07C1F90-9A11-4727-8756-9E03716F9AA2Q33975245-1371BEDA-02AD-4BFE-B2D4-4A25C95FD9AEQ34037407-CD4051A2-60F9-46A2-8EC9-31274BA26F8CQ34053483-817F2EB4-2C40-4D8D-8D0C-55057B4743FFQ34061880-B2CB79DD-7013-4D8B-9E18-7F326F660874Q34065250-54DB7360-4B8D-49F8-AECB-8EB5724258B4Q34156390-3392B3A1-4F37-47EA-AA52-47F3D10C64B4Q34156396-4794BBA5-E6AD-44EB-A7A9-82D305A42A3AQ34181037-EBE71E4D-6C8F-4E36-AA4B-00817A380528Q34276987-36F3BB1B-B53B-4DC5-9B44-3B94AB7712F2Q34286750-D7F6EB12-96E8-4EDE-99A7-B496C9DEC7D6Q34639659-39DC56C8-0871-4C11-953F-291086C3AD0BQ34712405-E8FE149B-83CA-42D8-A31E-9B4D6780C9F8Q35166646-2B96778B-154C-4714-8931-06EA47462254Q35166691-CED7AD19-AC0B-45E2-B0C1-696BE50DF435Q35200040-BA786B7E-619D-4C4C-8B06-BC392C2E111AQ35387162-299FE969-0CF8-4723-9FBC-023965CD1679Q35512513-BBF76D8A-5B5E-4B20-B728-5FB5944B080EQ35825392-124C80A8-8E2D-44B7-B343-B47C0CF377F0Q36053445-CCDB7EF7-8EA2-48F8-82AE-93F2A911DDB8Q36059243-4BDE29C3-57E6-4F3D-87C3-02A51B299102Q36123475-6052ACE9-7163-476C-B9B8-C16F93B22C32Q36151807-51EDF0EE-C884-4B13-9247-1EFE0F20A580Q36315470-1FD9EECB-7CF7-4B0C-8F55-3EB30A4E2161Q36337373-8BB2002C-1D2D-4736-BBDB-1E40FF9C39F1Q36474241-556F77A9-1C55-4556-9600-CF704CD7F98CQ36652302-82680579-573E-49AD-B485-8C4B09780BB0Q36734255-00211E8E-A7B8-4271-9753-E5FE380492A2Q36823793-71072572-1AA0-44F3-8E60-07FD89D3F8E5Q36897831-8DBBCA6D-252E-478A-AE7A-16E75527C280Q37162710-0345845F-D68C-4D4C-91AA-CFD7D0ED9431Q37277510-2A8B188A-9BD4-45C0-80FE-D3D0FC45EFDEQ37540904-307CA58D-606C-455E-9B15-2E69AEA52233Q37717001-CE13E822-6F31-4D76-8D63-AEF17D6FFFE7Q37789318-2BAF57D7-17A7-468C-84CB-22F2BC4E275D
P2860
Prescribing for the elderly. Part I: Sensitivity of the elderly to adverse drug reactions.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Prescribing for the elderly. P ...... rly to adverse drug reactions.
@en
Prescribing for the elderly. P ...... rly to adverse drug reactions.
@nl
type
label
Prescribing for the elderly. P ...... rly to adverse drug reactions.
@en
Prescribing for the elderly. P ...... rly to adverse drug reactions.
@nl
prefLabel
Prescribing for the elderly. P ...... rly to adverse drug reactions.
@en
Prescribing for the elderly. P ...... rly to adverse drug reactions.
@nl
P2860
P1476
Prescribing for the elderly. P ...... rly to adverse drug reactions.
@en
P2093
P2860
P304
P356
10.1111/J.1532-5415.1988.TB01785.X
P407
P577
1988-02-01T00:00:00Z